Status:
COMPLETED
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
Lead Sponsor:
Planned Parenthood League of Massachusetts
Collaborating Sponsors:
Society of Family Planning
Conditions:
Medical Abortion
Eligibility:
FEMALE
18-64 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women randomized to ul...
Eligibility Criteria
Inclusion
- Pregnant women undergoing medical abortion
- Proficiency in English
- Working phone and willingness to be contacted by phone
- Agreeing to surveys regarding demographics, follow-up preferences, and satisfaction with chosen follow-up method
Exclusion
- Concern for ectopic pregnancy or unable to document intrauterine pregnancy
- Clinical instability or signs of pelvic infection
- Medical conditions that contraindicate medical abortion
- Unwilling or unable to comply with study follow-up procedures
- Being in a situation where receiving phone calls or additional contact with research staff may endanger the privacy or safety of the subject (e.g., situations of domestic violence)
- Inability to give informed consent
- Previous participation in this study
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
376 Patients enrolled
Trial Details
Trial ID
NCT00907725
Start Date
May 1 2009
End Date
June 1 2010
Last Update
May 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood League of Massachusetts
Boston, Massachusetts, United States, 02215